Aripiprazole is an interesting psychoactive compound acting as a dopamine D2 partial agonist, serotonin 5-HT(1A) partial agonist and serotonin 5-HT(2A) antagonist. Aripiprazole possesses a well-documented efficacy in the treatment of both positive and negative psychotic symptoms. However, this medication may be rarely associated with the onset of hiccup. Here, we present the case of aripiprazole-induced hiccup in a young inpatient at his first psychiatric admission together with a review of the current literature about this topic. The possible etiology underlying the emergence of hiccups together with the clinical implications of this adverse event are discussed.

Aripiprazole-induced persistent HiCCup. A case report and review of the literature / Serafini, G.; Piccinini, G.; Visimberga, S.; Cervetti, A.; Murri, M. B.; Monacelli, F.; Pompili, M.; Amore, M.. - In: PSYCHIATRIA DANUBINA. - ISSN 0353-5053. - 31:1(2019), pp. 26-31. [10.24869/psyd.2019.26]

Aripiprazole-induced persistent HiCCup. A case report and review of the literature

Pompili M.
Penultimo
;
2019

Abstract

Aripiprazole is an interesting psychoactive compound acting as a dopamine D2 partial agonist, serotonin 5-HT(1A) partial agonist and serotonin 5-HT(2A) antagonist. Aripiprazole possesses a well-documented efficacy in the treatment of both positive and negative psychotic symptoms. However, this medication may be rarely associated with the onset of hiccup. Here, we present the case of aripiprazole-induced hiccup in a young inpatient at his first psychiatric admission together with a review of the current literature about this topic. The possible etiology underlying the emergence of hiccups together with the clinical implications of this adverse event are discussed.
2019
adverse effects; aripiprazole; hiccup; tolerability; humans; piperazines; antipsychotic agents; aripiprazole; hiccup; quinolones
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Aripiprazole-induced persistent HiCCup. A case report and review of the literature / Serafini, G.; Piccinini, G.; Visimberga, S.; Cervetti, A.; Murri, M. B.; Monacelli, F.; Pompili, M.; Amore, M.. - In: PSYCHIATRIA DANUBINA. - ISSN 0353-5053. - 31:1(2019), pp. 26-31. [10.24869/psyd.2019.26]
File allegati a questo prodotto
File Dimensione Formato  
Serafini_Aripiprazole-Induced_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 105.67 kB
Formato Adobe PDF
105.67 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1521135
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact